Can sulfasalazine therapy induce or exacerbate Wegener's granulomatosis?

Scandinavian Journal of Rheumatology

Volumn 37, Issue 1, 2008, Pages 72-74

  Denissen, N H A M ^a   Peters, J G P ^b   Masereeuw, R ^b   Barrera, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; C-REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; SULFASALAZINE; WEGENER GRANULOMATOSIS;

EID: 38149085979     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701607117     Document Type: Article

References (15)

1. Laversuch CJ, Collins DA, Charles PJ, Bourke BE. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Br J Rheumatol 1995;34:435-9.
2. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000;43:405-13.
3. Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 1997;36:1089-94.
4. Choi HK, Slot MC, Pan G, Weissbach CA, Niles JL, Merkel PA. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum 2000;43:2488-92.
5. Gordon MM, Porter DR, Capell HA. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Ann Rheum Dis 1999;58:288-90.
6. Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:2089-94.
7. Douglas G, Bird K, Flume P, Silver R, Bolster M. Wegener's granulomatosis in patients with rheumatoid arthritis. J Rheumatol 2003;30:2064-9.
8. Chinoy H, McKenna F. Wegener's granulomatosis and rheumatoid arthritis overlap. Rheumatology (Oxford) 2002;41:588-9.
9. Drayer DE, Reidenberg MM. Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther 1977;22:251-8.
10. Gunnarsson I, Nordmark B, Hassan BA, Grondal G, Larsson P, Forslid J, et al. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment - the role of IL-10 and HLA. Rheumatology (Oxford) 2000;39:886-93.
11. Rodenburg RJ, Ganga A, van Lent PL, van de Putte LB, van Venrooij WJ. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis. Arthritis Rheum 2000;43:1941-50.
12. Habens F, Srinivasan N, Oakley F, Mann DA, Ganesan A, Packham G. Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity. Apoptosis 2005;10:481-91.
13. Akahoshi T, Namai R, Sekiyama N, Tanaka S, Hosaka S, Kondo H. Rapid induction of neutrophil apoptosis by sulfasalazine: implications of reactive oxygen species in the apoptotic process. J Leukoc Biol 1997;62:817-26.
14. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997;100:1416-24.
15. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004;114:468-77.